← FDA Drug Approvals (Drugs@FDA)

INTEGRILIN

NDA · New Drug Application · Sponsor: MSD SUB MERCK · Approved 1998-05-18

Drug application

FDA Application #

NDA020718

Application type

New Drug Application

Brand name

INTEGRILIN

Generic name

Eptifibatide

Active ingredients

EPTIFIBATIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

MSD SUB MERCK

First approval

1998-05-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown